ABSTRACT-To assess the cardiovascular effects of a new class I antiarrhythmic agent, NIK-244, and to compare them with those of flecainide, canine isolated, sinoatri al node, papillary muscle and atrioventricular node preparations cross-circulated with a donor dog were used. NIK-244 injected intraarterially into the isolated preparations showed dose-related negative chronotropic, negative inotropic, and coronary vasodila tor effects, which are comparable to those of flecainide, and it also showed a dose-re lated negative dromotropic effect on both atrio-His (AH) and His-ventricular (HV) conduction. The prolongation of AH interval by NIK-244 was significantly more po tent than that by flecainide, while that of the HV interval by NIK-244 was slightly more potent, but not significantly, compared with that by flecainide. NIK-244 admin istered intravenously into the donor dog showed bradycardic and depressor effects in both the donor dog and the cross-circulated sinus node and papillary muscle prepara tions, which are comparable to the effects of flecainide. Although the negative dro motropic effects of NIK-244 on both the donor dog heart and the cross-circulated atrioventricular node preparation started more slowly, they were more potent and longer-lasting than those of flecainide. Our results suggest that NIK-244 may be a more powerful and longer-lasting antiarrhythmic agent than flecainide, since the anti arrhythmic action of class I drugs is considered to result from inhibition of the fast in ward current, which is the most important depolarizing current responsible for the in traatrial and His-Purkinje-ventriclar conduction.
produces no change in APD and is a slow kinetic drug. NIK-244 was reported to be effective on a variety of experimental (4) (5) (6) and clinical arrhythmias (1, 7) . In addition, to assess their antiarrhythmic effectiveness of a drug, it is also important to know its effects on cardiohemodynamics because arrhythmias often occur in impaired hearts and vice versa.
The purpose of the present study was to assess the cardiovascular effects of NIK-244 in comparison with those of flecainide. We used isolated canine SA node, PM and AV node preparations cross-circulated with a donor dog, which permit precise measurement of drug effects under both in vivo and in vitro conditions (8) (9) (10) (11) . Particularly, we could ex amine both the cardiohemodynamic effects in the donor dog and the direct cardiac effects in the isolated heart preparations simultaneously when the drugs were administered into the donor dog.
MATERIALS AND METHODS
Experiments were carried out on isolated canine SA node, PM and AV node prepara tions cross-circulated with heparinized arterial blood of a donor dog.
The isolated in vitro preparations
The hearts were obtained from mongrel dogs of either sex, weighing approximately 10 kg, which were anesthetized with sodium pen tobarbital (30 mg/kg, i.v.) and given calcium heparin (500 U/kg, i.v.). They were excised after exsanguination and plunged into cold Tyrode's solution kept at about 4°C.
The SA node preparation consisted of the entire right atrium. The sinus node artery was cannulated through the RCA. The spon taneous beating rate, i.e., SAR, was measured with a cardiotachograph (San-ei Instruments, 1321) triggered by bipolar atrial electrograms sutured on the atrial epicardium close to the sinus node.
The PM preparation consisted of the ante rior papillary muscle of the right ventricle attached to the interventricular septum. The ASA was directly cannulated. The PM prepa ration was electrically driven at a fixed rate of 120 beats/min by a stimulator (Dia Medical, DHM-226-3) and an isolation unit (Dia Medi cal, DPS-110) with rectangular pulses of 1-3 V (about 20% above the threshold voltage) at 5-msec duration through bipolar stimulating electrodes sutured onto the base of the PM. DT of the PM preloaded with a 2-g weight was measured isometrically using a force dis placement transducer (Dia Medical, DRM 100S).
The AV node preparation consisted of both the right atrium and interventricular septum. The RCA and the ASA were directly cannu lated, while the PSA was cannulated through the left circumflex artery. The AV node prepa ration was electrically driven at a fixed rate of 150 beats/min by a stimulator (Dia Medi cal, DHM-226-3) and an isolation unit (Dia Medical, DPS-110) with rectangular pulses of 1 3 V (about 20% above the threshold volt age) at 5-msec duration through bipolar stimu lating electrodes sutured onto the crista termi nalis of the right atrium. Bipolar electrograms were recorded from the right atrium (A), His bundle (H) and the base of the anterior PM (V). These electrograms were fed to an auto matic interval meter (Dia Medical, DHM-226 1), which measures AH and HV intervals indi vidually with an analysis pitch of 1 msec. Since the PSA mainly supplies the AV node area and the ASA mainly supplies the His Purkinje-ventricle system, drugs selectively in jected into the PSA affect the AH interval, while drugs injected into the ASA predomi nantly affect the HV interval. However, drugs injected into the ASA occasionally altered the AH interval in addition to the HV interval, probably due to anastomosis which exists be tween the ASA and PSA.
Donor dogs
Adult mongrel dogs of either sex, weighing 14-23 kg, were used as donor dogs. Dogs were anesthetized with sodium pentobarbital (30 mg/kg, i.v.) and supplemented with 4-5 mg/kg every hour. At the start of cross-cir culation, calcium heparin (500 U/kg, i.v.) was given and 200 U/kg was supplemented every hour. Respiration was controlled using a dog respirator (Harvard, 607). The HR, mAP at the femoral artery, and lead II ECG were continuously monitored with a polygraph (San-ei Instruments, 361-6). The PQ interval and QRS width of the donor dog heart were directly measured from the lead II ECG re corded at a paper speed of 100 mm/sec every 5 min and when necessary.
Cross-circulation
Preparations were placed in a double-wall glass jacket maintained at 38°C by circulating warm water, and they were cross-circulated through each cannulated artery with heparin ized blood pumped from the carotid artery of the donor dog. The SA node and PM prepara tions were obtained from the same animal, while the AV node preparation was obtained from a different animal. Perfusion pressure was kept at 100 mmHg with a peristaltic pump (Cole-Parmer, 7553-00) and a Starling pneumatic resistance placed parallel to the perfusion circuit. Venous blood from the preparations and excess blood passing through the pneumatic resistance were collected in a blood reservoir and returned to the donor dog through the jugular vein. The rate of CBF through each nutrient artery was continuously measured with an electromagnetic flowmeter (Nihon-Kohden, MVF-1100).
Direct cardiac effects on in vitro preparations NIK-244 (1 to 300,ug) or flecainide (1 to 300 ug) was injected into each nutrient artery of the preparations over 4 sec with a microsy ringe (Terumo). Maximal changes in each pa rameter were measured and expressed as a percent of their basal values before injection, and the dose-response curves for the chrono tropic, inotropic, dromotropic and vasodilator effects were drawn.
Cardiohemodynamic effects in the donor dogs NIK-244 (1 mg/kg) or flecainide (1 mg/kg), in an estimated canine antiarrhythmic dose (5, 12) , was administered to the donor dog through the jugular vein for a period of 30 sec. Each drug caused cardiohemodynamic effects on the donor dog and also produced direct cardiac effects in the in vitro prepara tions after a time lag of 1 to 2 min. The time course of their effects on HR, mAP, PQ and QRS of the donor dog and on SAR of the SA node preparation, DT and CBF of the PM preparation, AH and HV intervals and CBF through the ASA of the AV node preparation were simultaneously recorded.
Drugs and statistics
Drugs used were NIK-244 (Nikken Chemi cal K.K., Tokyo, Japan) and flecainide acetate (Eisai K.K., Tokyo, Japan). The doses of drugs causing a 15% decrease in SAR, ED15(SAR); those causing a 50% decrease in DT, ED50(DT); those causing a 50% increase in CBF, ED50(CBF); those causing a 50% in crease in AH interval, ED50(AH); and those causing a 50% increase in HV interval, ED50(HV), were calculated for each experi ment using the least squares method. The data were presented as the mean ± S.E.M., and the statistical comparisons of mean values were evaluated by a paired t-test or unpaired t-test, and P values less than 0.05 were consi dered significant.
RESULTS
Effects of NIK-244 or flecainide injected direct ly into each nutrient artery of the in vitro prepa rations
The SA node preparation showed spon taneous regular automaticity. When NIK-244 or flecainide was injected into the rubber tube connecting the RCA, SAR dose-relatedly de creased. A typical experiment of NIK-244 is shown in Fig. IA and flecainide (Table 1) . When NIK-244 or flecainide was injected into the ASA of the PM preparation, DT de creased and CBF increased, dose-relatedly. The changes of DT were longer-lasting than those of CBF. A typical experiment of NIK 244 is shown in Fig. 2A . Dose-response curves for the negative inotropic effect and for the coronary vasodilator effect of NIK-244 and flecainide are shown in Fig. 2 , B and C, re spectively. There was no significant difference between the ED50(DT) values of NIK-244 and flecainide (Table 1 ). There was also no signifi cant difference between the ED50(CBF) values of both drugs (Table 1) . Fig. 2 . Negative inotropic and coronary vasodilator effects of NIK-244 and flecainide in the papillary mus cle (PM) preparation. The basal developed tension (DT) of the PM before NIK-244 was 5.9 ± 0.5 g (n = 10) and that before flecainide was 7.1 ± 0.7 g (n = 9). The basal coronary blood flow (CBF) through the anterior septal artery before NIK-244 was 5.4 ± 0.5 ml/min (n = 8) and that before flecainide was 5.7 ± 0.5 ml/min (n = 9). cainide. The ED50(AH) of NIK-244 was signi ficantly less than that of flecainide (Table 1) . On the other hand, when NIK-244 or fle cainide was injected into the ASA of the AV node preparation, the HV interval dose-re latedly increased, while the AH interval in creased only with larger doses of NIK-244 or flecainide. A typical experiment of NIK-244 is shown in Fig. 4A , in which the HV interval predominantly increased. Dose-response curves for the effects of NIK-244 and fle cainide on HV intervals are shown in Fig. 4B . There was no significant difference between the ED50(HV) values of NIK-244 and fle cainide (Table 1) . Effects of intravenous administration of NIK 244 and flecainide into the donor dogs Effects of NIK-244 on the donor dog: All the parameters of the donor dog changed within 30 sec after i.v. administration of NIK 244. HR gradually decreased during the observation period, and the value at 20 min was 92% of the basal level (Fig. 5A) . Mean arterial pressure decreased, reaching a peak response (90% of the basal value) at 1 min, and then gradually returned to the basal level (Fig. 5B) . PQ and QRS intervals increased, and reaching their peaks (127 and 132% of the basal values) at 10 min and 5 min, respec tively; and these increases were maintained during the observation period (Fig. 5, C and  D) .
Effects of flecainide on the donor dog: Simi lar to NIK-244, all the parameters of the donor dog changed within 30 sec after i.v. administration of flecainide. HR rapidly de creased, reaching a peak (94% of the basal value) at 3 min, and then gradually returned to the basal level (Fig. 5A) . Mean arterial pressure initially decreased for 0 to 30 sec, fol lowed by an increase toward the basal level for 30 sec to 1 min, then decreased again, reaching a peak (97% of the basal value) at 5 min and then gradually returned to the basal level (Fig. 513) . PQ and QRS rapidly in creased, reaching their peaks (117 and 118% of the basal values) at 2 min and 1 min, re spectively, then gradually returned to the ba sal level (Fig. 5, C and D) .
The percent change in HR at 1 min after i.v. NIK-244 was significantly less than that af ter flecainide (Fig. 5A) . The percent changes in mAP at 1 to 2 min after i.v. NIK-244 were significantly larger than those after flecainide (Fig. 5B) . The percent changes in PQ interval at 0.5 to 2 min after i.v. NIK-244 were signifi cantly less than those after flecainide, while the percent changes in PQ interval at 5 to 20 min were significantly larger than those after flecainide (Fig. 5C) . The percent change in QRS width at 0.5 min after 1.v. NIK-244 was significantly less than that after flecainide, while the percent changes in QRS width at 10 to 20 min after i.v. NIK-244 were larger than those after flecainide (Fig. 5D) . Fig. 5 . Time courses of effects of 1 mg/kg of NIK-244 or flecainide administered intravenously to the donor dog on the heart rate (HR) (A), the mean arterial pressure (mAP) (B), the PQ interval (C) and QRS width (D) of the donor dog. The basal HR before NIK-244 was 112 ± 9 beats/min (n = 10) and that before flecainide was 112 ± 11 beats/min (n = 10). The basal mAP before NIK-244 was 100 ± 6 mmHg (n = 10) and that before flecainide was 100 ± 9 mmHg (n = 10). The basal PQ interval before NIK-244 was 113 ± 5 msec (n = 10) and that before flecainide was 112 ± 5 msec (n = 10). The basal QRS width before NIK-244 was 63 ± 3 msec (n = 10) and that before flecainide was 62 ± 3 msec (n = 10). Closed circles of NIK-244 represent significant difference from the values of flecainide observed at the same time after injec tion (P < 0.05). Asterisks represent significant changes from the 0 time values. *P < 0.05, **P < 0.01. Effects of NIK-244 given into the donor dog on the in vitro preparations: After i.v. adminis tration of NIK-244, SAR started to decrease within 1 to 2 min after injection, reaching a minimum (94% of the basal value) at 10 min, and then gradually returned to the basal level (Fig. 6A) . DT also decreased, reaching a minimum (83% of the basal value) at 7 min and then gradually returned to the basal level (Fig. 6B) . CBF transiently increased, reaching a peak (126% of the basal value) at 3 min, then gradually returned to the basal level (Fig.  6C ). AH and HV intervals increased, reaching their maximum values (147% and 158% of the basal values) at 10 and 7 min, respectively; and these increases were maintained during the observation period (Fig. 6, D and E) .
Second degree AH conduction block occurred in 1 out of 4 preparations at 15 min and per sisted during the observation period.
The maximal percent changes of parameters in the in vitro preparation after i.v. adminis tration of 1 mg/kg of NIK-244 into the donor dog were the same as those produced by about 20 jig to 300 jig of NIK-244 directly in jected into the nutrient arteries of the prepa rations. Fig. 6 . Time courses of effects of 1 mg/kg of NIK-244 or flecainide administered intravenously to the donor dog on SAR of the SA node preparation (A), DT of the PM preparation (B), CBF through the ASA of the PM and AV node preparations (C) and on AH (D) and HV (E) intervals of the AV node prepara tion. The basal SAR before NIK-244 was 105 ± 8 beats/min (n = 4) and that before flecainide was 107 ± 6 beats/min (n = 4). The basal DT before NIK-244 was 7.2 ± 0.8 g (n = 6) and that before flecainide was 7.2 ± 0.8 g (n = 6). The basal CBF before NIK-244 was 7.3 ± 0.9 ml/min (n = 10) and that before fle cainide was 7.1 ± 0.5 ml/min (n = 10). The basal AH and HV intervals before NIK-244 were 107 ± 9 and 43 ± 4 msec (n = 4) and those before flecainide were 110 ± 4 msec and 45 ± 4 msec (n = 4). Closed circles of NIK-244 represent a significant difference from the values of flecainide observed at the same time after injection (P < 0.05). Asterisks represent significant changes from the 0 time values, *P < 0.05, **P < 0.01. -0 -9 NIK-244; -o flecainide.
Effects of flecainide given into the donor dog on the in vitro preparations: SAR decreased, reaching a minimum (93% of the basal value) at 3 min, and then gradually returned to the basal level (Fig. 6A) . DT decreased, reaching the peak decrease (88% of the basal value) at 5 min and then gradually returned to the basal level (Fig. 613) . CBF transiently increased, reaching a peak (107% of the basal value) at 2 min, then gradually returned to the basal level (Fig. 6C) . AH and HV rapidly increased, reaching their maximum (127% and 125% of the basal values) at 5 min, and then gradually returned to their respective basal levels (Fig.  6, D and E) .
The maximal percent changes of the param eters in the in vitro preparation after i.v. administration of 1 mg/kg of flecainide into the donor dog were the same as those pro duced by about 10 ,ug to 200,ug of flecainide directly injected into the nutrient arteries of the preparations.
There was no significant difference in the percent changes of SAR between NIK-244 and flecainide at the corresponding time after i.v. administration (Fig. 6A) . The percent change in DT at 10 min after i.v. NIK-244 was signifi cantly larger than that after flecainide (Fig.  6B) . The percent changes in CBF at 3 to 7 min after i.v. NIK-244 were significantly larger than those after flecainide (Fig. 6C) . The per cent changes in AH interval at 0.5 to 3 min after i.v. NIK-244 were significantly less than those after i.v. flecainide, while the percent changes in AH interval at 7 to 20 min after i.v. NIK-244 were larger than those after i.v. flecainide. The percent changes in HV interval at 0.5 to 3 min after i.v. NIK-244 were signifi cantly less than those after flecainide, while the percent changes in HV interval at 7 to 20 min after i.v. NIK-244 were significantly larger than those after i.v. flecainide (Fig. 6E) .
DISCUSSION
The present study using the blood-perfused isolated heart preparations revealed the direct and indirect effects of NIK-244 on cardiac properties in comparison with flecainide. NIK 244 injected directly into the SA node and PM preparations showed negative chronotropic, negative inotropic and coronary vasodilator effects, which were comparable to those of fle cainide. Similar results on the negative inotro pic action of NIK-244 were reported by others (4, 13, 14) . NIK-244 injected directly into the AV node preparations showed a negative dro motropic effect on AH and HV conductions. The effect on AH interval of NIK-244 was sig nificantly more potent than that of flecainide, while the effect on HV interval of NIK-244 was slightly more potent, but not significantly, compared with flecainide. NIK-244 adminis tered i.v. into the donor dog showed bradycar dic and depressor effects on the donor dog similar to flecainide, while although the nega tive dromotropic effects on the PQ interval and QRS width of NIK-244 started more slow ly, they were more potent and longer-lasting than those of flecainide. In the in vitro prepa rations cross-circulated by arterial blood of the donor dog given NIK-244 or flecainide, i.v., cardiodepressant and coronary vasodilator effects also appeared. NIK-244 that was i.a.-injected into the RCA decreased SAR of the SA node preparation in a dose-dependent manner. NIK-244 that was i.v.-administered into the donor dog also caused bradycardia in the donor dog and de creased SAR of the cross-circulated SA node preparation. These results are consistent with a previous report that NIK-244 has a direct negative chronotropic effect in the intact canine heart in situ (2). Urthaler et al. (2) par tially attributed this effect of NIK-244 to its depressing actions on sinus node automaticity which were mainly mediated through a de creased activity of the slow current-dependent cells of the sinus node.
Flecainide significantly decreased the mAP only at 2 min, while NIK-244 significantly de creased the mAP at 0.5 to 5 min. Since the direct negative chronotropic and inotropic effects of NIK-244 were almost the same as those of flecainide, respectively, and NIK-244 has been reported not to interfere with reflex mediated cardiovascular adaptive changes (15) , NIK-244 must possess a more potent direct vasodilator effect on peripheral vascula ture compared to flecainide. Whether this effect of NIK-244 on the vasculature is favor able clinically or not must be determined by further studies.
It has been reported that almost all the class I antiarrhythmic agents transiently increased CBF, when they were directly injected into isolated canine blood-perfused heart prepara tions (8, 11) . However, some of them have not shown significant coronary vasodilator effects even in the isolated preparations, when administered intravenously (11). In our study, i.a. and i.v. NIK-244 as well as flecainide tran siently increased CBF of the preparation.
In the AV node preparation, NIK-244 pro longed the AH as well as HV intervals, which is consistent with the previous report by Urthaler et al. (2) . Antiarrhythmic action of class I drugs is considered to result from their membrane effects; namely, an inhibition of the fast inward current, because we showed in earlier studies that the antiarrhythmic effect of class I drugs on canine coronary ligation and digitalis induced arrhythmias occurred at con centrations decreasing the Na current (5, 12) . Since Na current is the most important de polarizing current responsible for the intra atrial and His-Purkinje-ventricle conduction, our results that the effect of i.a. NIK-244 on AH was significantly more potent than that of i.a. flecainide, while the effect of La. NIK-244 on HV was slightly more potent compared with La. flecainide, suggest that NIK-244 at least possesses an electrophysiologic profile similar to that of the well-established class I agent flecainide.
NIK-244 i.v. administered to the donor dog showed significantly slower onset and longer lasting negative dromotropic effects on PQ and QRS of the donor heart and on AH and HV conductions of the cross-circulated AV node preparation than flecainide, although the pharmacokinetics of the two drugs are similar (5, 12) . These results are in good accordance with our earlier report on dog Purkinje cells (3) , in which the slowly developing block of INa by NIK-244 and a much slower recovery from use-dependent block than flecainide were demonstrated. Therefore, these findings indi cate that NIK-244 should be classified as a slower kinetic drug than flecainide, and this may be related to the significantly more po tent negative dromotropism by i.a. NIK-244 in AH conduction than that by La. flecainide.
In summary, NIK-244 has negative chrono tropic, inotropic and vasodilator effects which are comparable to flecainide, while its nega tive dromotropic effect is more potent and slower in on-set and longer-lasting than fle cainide. As these properties of the negative dromotropic effect might explain the previous report that NIK-244 is a more potent anti arrhythmic drug on canine coronary ligation induced, and digitalis-induced arrhythmias in terms of the low dose or concentration to sup press arrhythmias than flecainide (5, 12) . As a result, NIK-244 may prove to be a powerful antiarrhythmic agent as has already been shown in studies using a limited number of pa tients (1, 7) .
